Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

计划入组 157 人 · 首次发布于 2008 年 12 月 18 日

A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)

计划入组 35 人 · 首次发布于 2021 年 11 月 16 日

A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis

计划入组 14 人 · 首次发布于 2019 年 7 月 2 日

OAK-0011379

OAK-0011799

HC-010

Hc Jones, Inc.

United States

HC HEALTHCARE PTE. LTD.

Singapore

OAK HILL BIO LTD

United Kingdom

Chai Discovery Raises $130M Series B to Accelerate AI-Driven Drug Discovery Platform

Dash Bio Raises $30M Series A to Modernize Bioanalysis and Accelerate Drug Development Timelines

Courier Health Secures $50M Series B to Advance AI-Powered Patient Engagement Platform for Specialty Therapies